US Foods Holding Corp.: Form 10-Q for the period ended Jun 27, 2026
Filed with the SEC on Aug 6, 2026 and accepted by EDGAR at Aug 6, 2026, 16:14 ET.
Management's discussion and analysis
As filed, 36,719 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
(Dollar amounts in tables presented in millions, unless otherwise noted)
The following discussion and analysis should be read together with the accompanying unaudited consolidated financial statements and the notes thereto included in this Quarterly Report and the audited consolidated financial statements and the notes thereto in the 2025 Annual Report. The following discussion and analysis contain certain financial measures that are not required by or presented in accordance with GAAP. We believe these non-GAAP measures provide meaningful supplemental information about our operating performance and liquidity. Information regarding reconciliations of and the rationale for these measures is discussed under “Non-GAAP Reconciliations” below. Results of operations for the 13 weeks and 26 weeks ended June 27, 2026 are compared to the 13 weeks and 26 weeks ended June 28, 2025, unless specifically noted otherwise.
Overview
At US Foods, we strive to inspire and empower chefs and foodservice operators to bring great food experiences to consumers. This mission is supported by our strategy of WE HELP YOU MAKE IT®. Our Promise brings three key elements to the forefront for our customers: (1) more quality products, like our large and diverse portfolio of Exclusive Brands that is based on consistency, freshness and innovation; (2) more tools, centering on our MOXē® business platform, and lastly; (3) more deliveries, with options for on-time deliveries enabled by our traditional broadline services and our flexible and convenient Pronto® program. We operate as one business with standardized business processes, shared systems infrastructure, and an organizational model that optimizes national scale with local execution, allowing us to manage our business as a single operating segment. We have centralized activities where scale matters and our local field structure focuses on customer-facing activities.
We supply approximately 250,000 customer locations nationwide. These customer locations include independent restaurants, chain restaurants, healthcare, hospitality, government and education customers. We provide fresh, frozen, and dry food products, as well as non-food items, sourced from thousands of suppliers. Over 4,000 sales associates manage customer relationships at local, regional, and national levels. Our sales associates are supported by sophisticated marketing and category management capabilities, as well as world-class chefs, business development managers and others that help us to provide more comprehensive service to our customers. Our relationship with our customers is further strengthened by our industry-leading MOXē® digital platform that makes it easy for our customers to manage their orders and inventories, while also providing valuable support for their business. Our extensive network of over 70 distribution facilities and fleet of over 6,500 trucks, along with over 90 cash and carry locations, allow us to operate efficiently and provide high levels of customer service. This operating model allows us to leverage our nationwide scale and footprint while executing locally.
Operating Metrics
*Case volume—*Case volume, by customer type (e.g., independent restaurants) is reported as of a point in time. Customers periodically are reclassified, based on changes in size or other characteristics, and when those changes occur, the respective customer’s historical volume is included within the new classification.
*Organic volume—*Organic volume includes volume from operating businesses that have been reflected in our results of operations for at least 12 months.
Highlights
For the 13 weeks ended June 27, 2026, compared to the same period a year ago, total case volume increased 1.9%, driven by a 5.1% increase in independent restaurant case volume, a 3.5% increase in healthcare volume and a 4.4% increase in hospitality volume, partially offset by a 1.5% decrease in chain volume.
For the 26 weeks ended June 27, 2026, compared to the same period a year ago, total case volume increased 1.6%, driven by a 4.8% increase in independent restaurant case volume, a 3.6% increase in healthcare volume and a 4.8% increase in hospitality volume, partially offset by a 1.9% decrease in chain volume.
For the 13 weeks and 26 weeks ended June 27, 2026, compared to the same period a year ago, total organic case volume increased 1.7% and 1.4%, respectively, which includes 5.0% and 4.7% organic independent restaurant case volume growth for the 13 weeks and 26 weeks ended June 27, 2026, respectively.
Net sales increased $450 million, or 4.5%, and $709 million, or 3.6%, for the 13 weeks and 26 weeks ended June 27, 2026, respectively, driven by case volume growth and food cost inflation of 2.3% and 1.7% for the 13 weeks and 26 weeks ended June 27, 2026, respectively.
Gross profit increased $142 million, or 8.0%, to $1,919 million for the 13 weeks ended June 27, 2026, and increased $181 million or 5.3%, to $3,572 million for the 26 weeks ended June 27, 2026. For the 13 weeks ended June 27, 2026, the increase was primarily a result of an increase in total case volume, improved cost of goods sold and a favorable year-over-year LIFO adjustment. For the 26 weeks ended June 27, 2026, the increase was primarily a result of an increase in total case volume and improved cost of goods sold, partially offset by an unfavorable year-over-year LIFO adjustment. Gross profit was positively impacted by a decrease to LIFO reserve of $5 million for the 13 weeks ended June 27, 2026 and negatively impacted by LIFO expense of $33 million for the 26 weeks ended June 27, 2026. Gross profit was negatively impacted by LIFO expense of $14 million and $19 million for the 13 weeks and 26 weeks ended June 28, 2025, respectively. As a percentage of net sales, gross profit was 18.2% and 17.6% for the 13 weeks ended June 27, 2026, and June 28, 2025, respectively, and 17.7% and 17.4% for the 26 weeks ended June 27, 2026 and June 28, 2025, respectively.
Total operating expenses increased $71 million, or 5.1%, to $1,476 million for the 13 weeks ended June 27, 2026, and increased $118 million, or 4.2%, to $2,913 million for the 26 weeks ended June 27, 2026. For the 13 weeks and 26 weeks ended June 27, 2026, the increase was primarily a result of an increase in total case volume and higher distribution, selling and administrative costs, partially offset by actions to streamline administrative processes and costs. As a percentage of net sales, operating expenses were 14.0% and 13.9% for the 13 weeks ended June 27, 2026 and June 28, 2025, respectively, and 14.5% and 14.4% for the 26 weeks ended June 27, 2026 and June 28, 2025, respectively.
Results of Operations
The following table presents selected historical results of operations for the periods indicated:
| Consolidated Statements of Operations: | 13 weeks ended June 27, 2026 | June 28, 2025 | 26 weeks ended June 27, 2026 | June 28, 2025 |
|---|---|---|---|---|
| Net sales | $10,532 | $10,082 | $20,142 | $19,433 |
| Cost of goods sold | 8,613 | 8,305 | 16,570 | 16,042 |
| Gross profit | 1,919 | 1,777 | 3,572 | 3,391 |
| Operating expenses: | ||||
| Distribution, selling and administrative costs | 1,477 | 1,403 | 2,906 | 2,788 |
| Restructuring activity and asset impairment charges | (1) | 2 | 7 | 7 |
| Total operating expenses | 1,476 | 1,405 | 2,913 | 2,795 |
| Operating income | 443 | 372 | 659 | 596 |
| Other income—net | (3) | (2) | (4) | (3) |
| Interest expense—net | 77 | 74 | 152 | 151 |
| Income before income taxes | 369 | 300 | 511 | 448 |
| Income tax provision | 94 | 76 | 120 | 109 |
| Net income | 275 | 224 | 391 | 339 |
| Percentage of Net Sales: | ||||
| Gross profit | 18.2% | 17.6% | 17.7% | 17.4% |
| Operating expenses | 14.0% | 13.9% | 14.5% | 14.4% |
| Operating income | 4.2% | 3.7% | 3.3% | 3.1% |
| Net income | 2.6% | 2.2% | 1.9% | 1.7% |
| Adjusted EBITDA(1) | 5.7% | 5.4% | 5.0% | 4.8% |
| Other Data: | ||||
| Cash flows—operating activities | $431 | $334 | $725 | $725 |
| Cash flows—investing activities | (78) | (75) | (175) | (205) |
| Cash flows—financing activities | (346) | (299) | (535) | (518) |
| Capital expenditures | 76 | 77 | 174 | 161 |
| EBITDA(1) | 564 | 489 | 900 | 826 |
| Adjusted EBITDA(1) | 604 | 548 | 1,017 | 937 |
| Adjusted Net Income(1) | 317 | 277 | 491 | 436 |
| Free Cash Flow(2) | 355 | 261 | 552 | 569 |
(1) EBITDA is defined as net income, plus interest expense—net, income tax provision, and depreciation and amortization. Adjusted EBITDA is defined as EBITDA adjusted for: (1) restructuring activity and asset impairment charges; (2) share-based compensation expense; (3) the impact of LIFO reserve adjustments; (4) loss on extinguishment of debt; (5) business transformation costs; and (6) other gains, losses, or costs as specified in the agreements governing our indebtedness. Adjusted EBITDA Margin is Adjusted EBITDA divided by total net sales. Adjusted Net Income is defined as net income excluding the items used to calculate Adjusted EBITDA listed above and further adjusted for the tax effect of the exclusions and discrete tax items. EBITDA, Adjusted EBITDA, and Adjusted Net Income as presented are supplemental measures of our performance that are not required by, or presented in accordance with, GAAP. They are not measurements of our performance under GAAP and should not be considered as alternatives to net income or any other performance measures derived in accordance with GAAP. For additional information, see the discussion under the caption “Non-GAAP Reconciliations” below.
(2) Free Cash Flow is defined as cash flows provided by operating activities and proceeds from sales of property and equipment less cash capital expenditures. Free Cash Flow as presented is a supplemental measure of our liquidity that is not required by, or presented in accordance with, GAAP. It is not a measure of our liquidity under GAAP and should not be considered as an alternative to cash flows provided by operating activities or any other liquidity measures derived in accordance with GAAP. For additional information, see the discussion under the caption “Non-GAAP Reconciliations” below.
Non-GAAP Reconciliations
We provide EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income and Free Cash Flow as supplemental measures to GAAP financial measures regarding our operating performance and liquidity. These non-GAAP financial measures, as defined above, exclude the impact of certain items and, therefore, have not been calculated in accordance with GAAP.
We believe EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin provide meaningful supplemental information about our operating performance because they exclude amounts that we do not consider part of our core operating results when assessing our performance.
We believe that Adjusted Net Income is a useful measure of operating performance for both management and investors because it excludes items that are not reflective of our core operating performance and provides an additional view of our operating performance including depreciation, interest expense and income taxes on a consistent basis from period to period. We believe that Adjusted Net Income may be used by investors, analysts and other interested parties to facilitate period-over-period comparisons and provides additional clarity as to how factors and trends impact our operating performance.
Management uses these non-GAAP financial measures (1) to evaluate our historical and prospective financial performance as well as our performance relative to our competitors as they assist in highlighting trends, (2) to set internal sales targets and spending budgets, (3) to measure operational profitability and the accuracy of forecasting, (4) to assess financial discipline over operational expenditures, and (5) as an important factor in determining variable compensation for management and employees. EBITDA and Adjusted EBITDA are also used in connection with certain covenants and activity restrictions under the agreements governing our indebtedness. We also believe these and similar non-GAAP financial measures are frequently used by securities analysts, investors, and other interested parties to evaluate companies in our industry. EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted Net Income are not measurements of our performance under GAAP and should not be considered as alternatives to net income or any other performance measures derived in accordance with GAAP.
We use Free Cash Flow as a supplemental measure to GAAP financial measures regarding the liquidity of our operations. We measure Free Cash Flow as cash flows provided by operating activities and proceeds from sales of property and equipment less cash capital expenditures. We believe that Free Cash Flow is a useful financial metric to assess our ability to pursue business opportunities and investments. Free Cash Flow is not a measure of our liquidity under GAAP and should not be considered as an alternative to cash flows provided by operating activities or any other liquidity measures derived in accordance with GAAP.
We caution readers that amounts presented in accordance with our definitions of EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, and Free Cash Flow may not be the same as similar measures used by other companies. Not all companies and analysts calculate EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income or Free Cash Flow in the same manner. We compensate for these limitations by using these non-GAAP financial measures as supplements to GAAP financial measures and by presenting the reconciliations of the non-GAAP financial measures to their most comparable GAAP financial measures.
The following table reconciles EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income and Free Cash Flow to the most directly comparable GAAP financial performance and liquidity measures for the periods indicated:
| 13 weeks ended June 27, 2026 | June 28, 2025 | 26 weeks ended June 27, 2026 | June 28, 2025 | |||||
|---|---|---|---|---|---|---|---|---|
| Net income and Net income margin | $275 | 2.6% | $224 | 2.2% | 391 | 1.9% | 339 | 1.7% |
| Interest expense—net | 77 | 74 | 152 | 151 | ||||
| Income tax provision | 94 | 76 | 120 | 109 | ||||
| Depreciation expense | 104 | 102 | 209 | 200 | ||||
| Amortization expense | 14 | 13 | 28 | 27 | ||||
| EBITDA and EBITDA margin | 564 | 5.4% | 489 | 4.9% | 900 | 4.5% | 826 | 4.3% |
| Adjustments: | ||||||||
| Restructuring activity and asset impairment charges(1) | — | 2 | 8 | 7 | ||||
| Share-based compensation expense(2) | 32 | 23 | 54 | 45 | ||||
| LIFO reserve adjustments (3) | (5) | 14 | 33 | 19 | ||||
| Business transformation costs(4) | 10 | 13 | 17 | 20 | ||||
| Business acquisition, integration related costs, divestitures and other(5) | 3 | 7 | 5 | 20 | ||||
| Adjusted EBITDA and Adjusted EBITDA margin | 604 | 5.7% | 548 | 5.4% | 1,017 | 5.0% | 937 | 4.8% |
| Depreciation expense | (104) | (102) | (209) | (200) | ||||
| Interest expense—net | (77) | (74) | (152) | (151) | ||||
| Income tax provision, as adjusted(6) | (106) | (95) | (165) | (150) | ||||
| Adjusted Net Income | $317 | $277 | $491 | $436 | ||||
| Cash flow | ||||||||
| Cash flows from operating activities | $431 | $334 | $725 | $725 | ||||
| Proceeds from sales of property and equipment | — | 4 | 1 | 5 | ||||
| Capital expenditures | (76) | (77) | (174) | (161) | ||||
| Free Cash Flow | $355 | $261 | $552 | $569 |
(1) Consists primarily of severance and related costs, organizational realignment costs and asset impairment charges.
(2) Share-based compensation expense for expected vesting of stock awards and employee stock purchase plan.
(3) Represents the impact of LIFO reserve adjustments.
(4) Transformational costs represent non-recurring expenses prior to formal launch of strategic projects with anticipated long-term benefits to the Company. These costs generally relate to third party consulting and non-capitalizable technology. For both the 13 weeks and 26 weeks ended June 27, 2026 and June 28, 2025, business transformation costs related to projects associated with information technology infrastructure initiatives and workforce efficiencies.
(5) Includes: (i) aggregate acquisition, integration related costs and divestiture costs of $1 million and $7 million for the 13 weeks and 26 weeks ended June 27, 2026 and June 28, 2025, respectively, and $2 million and $20 million for the 26 weeks ended June 27, 2026 and June 28, 2025, respectively; and (ii) other gains, losses or costs that we are permitted to addback for purposes of calculating Adjusted EBITDA under certain agreements governing our indebtedness.
(6) Represents our income tax provision adjusted for the tax effect of pre-tax items excluded from Adjusted Net Income and the removal of applicable discrete tax items. Applicable discrete tax items include changes in tax laws or rates, changes related to prior year unrecognized tax benefits, discrete changes in valuation allowances, and excess tax benefits associated with share-based compensation. The tax effect of pre-tax items excluded from Adjusted Net Income is computed using a statutory tax rate after taking into account the impact of permanent differences and valuation allowances.
A reconciliation between the GAAP income tax provision and the income tax provision, as adjusted, is as follows:
| 13 weeks ended June 27, 2026 | June 28, 2025 | 26 weeks ended June 27, 2026 | June 28, 2025 | |
|---|---|---|---|---|
| GAAP income tax provision | $94 | $76 | $120 | $109 |
| Tax impact of pre-tax income adjustments | 11 | 17 | 33 | 33 |
| Discrete tax items | 1 | 2 | 12 | 8 |
| Income tax provision, as adjusted | $106 | $95 | $165 | $150 |
19
Comparison of Results
13 weeks ended June 27, 2026 and June 28, 2025
Highlights
- Net sales increased $450 million, or 4.5%, to $10,532 million in 2026.
- Total case volume increased 1.9% and independent restaurant case volume increased 5.1%.
- Total organic case volume increased 1.7% and organic independent restaurant case volume increased 5.0%.
- Operating income increased $71 million to $443 million in 2026.
- Net income increased $51 million to $275 million in 2026.
- Adjusted EBITDA increased $56 million, or 10.2%, to $604 million in 2026.
- Adjusted EBITDA as a percentage of net sales was 5.7% in 2026, compared to 5.4% in 2025.
Net Sales
Net sales increased $450 million or 4.5%, to $10,532 million in 2026, driven by case volume growth and food cost inflation of 2.3%. Total case volume increased 1.9% driven by a 5.1% increase in independent restaurant case volume, a 3.5% increase in healthcare volume and a 4.4% increase in hospitality volume, partially offset by a 1.5% decrease in chain volume. Total organic case volume increased 1.7% and organic independent restaurant case volume increased 5.0%. Organic broadline cases of private brands represented approximately 35% of total cases in 2026 and 2025.
Gross Profit
Gross profit increased $142 million, or 8.0%, to $1,919 million in 2026, primarily as a result of an increase in total case volume, improved cost of goods sold, and a $19 million favorable year-over-year LIFO adjustment. Our LIFO method of inventory costing resulted in a benefit of $5 million in 2026 compared to $14 million expense in 2025, driven by a reduction in inflation and an decrease in inventory values in multiple categories. Gross profit as a percentage of net sales was 18.2% in 2026, compared to 17.6% in 2025.
Operating Expenses
Operating expenses, comprised of distribution, selling and administrative costs, increased $71 million, or 5.1%, to $1,476 million in 2026. Operating expenses increased primarily as a result of an increase in total case volume and higher distribution, selling and administrative costs, partially offset by actions to streamline administrative processes and costs. Operating expenses as a percentage of net sales were 14.0% in 2026, compared to 13.9% in 2025.
Operating Income
Our operating income was $443 million in 2026, compared to operating income of $372 million in 2025. The increase in operating income was due to the factors discussed in the relevant sections above.
Other Income—Net
Other income—net includes components of net periodic pension benefit credits, exclusive of the service cost component associated with our defined benefit and other postretirement plans. We recognized other income—net of $3 million in 2026 and $2 million in 2025.
Interest Expense—Net
Interest expense—net increased $3 million to $77 million in 2026 primarily due to higher borrowings under the ABL Facility, partially offset by lower interest rates for our variable rate debt.
Income Taxes
For the 13 weeks ended June 27, 2026, the Company’s effective income tax rate of 25% differed from the 21% federal corporate income tax rate primarily as a result of state income taxes and the recognition of various discrete tax items. These discrete tax items included a tax benefit of $1 million, primarily related to excess tax benefits associated with share-based compensation. For the 13 weeks ended June 28, 2025, the Company’s effective income tax rate of 25% differed from the 21% federal corporate income tax rate primarily as a result of state income taxes and the recognition of various discrete tax items. These discrete tax items included a tax benefit of $2 million, primarily related to excess tax benefits associated with share-based compensation.
Net Income
Our net income was $275 million in 2026, compared to a net income of $224 million in 2025. The improvement in net income was due to the relevant factors discussed above.
26 weeks ended June 27, 2026 and June 28, 2025
Highlights
- Net sales increased $709 million, or 3.6% to $20,142 million in 2026.
- Total case volume increased 1.6% and independent restaurant case volume increased 4.8%.
- Total organic case volume increased 1.4% and organic independent restaurant case volume increased 4.7%.
- Operating income increased $63 million to $659 million in 2026.
- Net income increased $52 million to $391 million in 2026.
- Adjusted EBITDA increased $80 million, or 8.5%, to $1,017 million in 2026.
- Adjusted EBITDA as a percentage of net sales was 5.0% in 2026, compared to 4.8% in 2025.
Net Sales
Net sales increased $709 million or 3.6%, to $20,142 million in 2026, driven by case volume growth and food cost inflation of 1.7%. Total case volume increased 1.6% driven by a 4.8% increase in independent restaurant case volume, a 3.6% increase in healthcare volume and a 4.8% increase in hospitality volume, partially offset by a 1.9% decrease in chain volume. Total organic case volume increased 1.4% and organic independent restaurant case volume increased 4.7%. Organic broadline cases of private brands represented approximately 35% of total cases in 2026 and 2025.
Gross Profit
Gross profit increased $181 million, or 5.3%, to $3,572 million in 2026, primarily as a result of an increase in total case volume and improved cost of goods sold, partially offset by a $14 million unfavorable year-over-year LIFO adjustment. Our LIFO method of inventory costing resulted in an expense of $33 million in 2026 compared to $19 million expense in 2025, driven by inflation and an increase in inventory values in multiple categories. Gross profit as a percentage of net sales was 17.7% in 2026, compared to 17.4% in 2025.
Operating Expenses
Operating expenses, comprised of distribution, selling and administrative costs, increased $118 million, or 4.2%, to $2,913 million in 2026. Operating expenses increased primarily as a result of an increase in total case volume and higher distribution, selling and administrative costs, partially offset by actions to streamline administrative processes and costs. Operating expenses as a percentage of net sales were 14.5% in 2026, compared to 14.4% in 2025.
Operating Income
Our operating income was $659 million in 2026, compared to operating income of $596 million in 2025. The increase in operating income was due to the factors discussed in the relevant sections above.
Other Income—Net
Other income—net includes components of net periodic pension benefit credits, exclusive of the service cost component associated with our defined benefit and other postretirement plans. We recognized other income—net of $4 million in 2026 and $3 million in 2025.
Interest Expense—Net
Interest expense—net increased $1 million to $152 million in 2026 primarily due to higher borrowings under the ABL Facility, partially offset by lower interest rates for our variable rate debt.
Income Taxes
For the 26 weeks ended June 27, 2026, the Company’s effective income tax rate of 23% differed from the 21% federal corporate income tax rate primarily as a result of state income taxes and the recognition of various discrete tax items. These discrete tax items included a tax expense of $4 million related to an unrecognized tax benefit due to tax positions taken in prior years and a tax benefit of $16 million, primarily related to excess tax benefits associated with share-based compensation. For the 26 weeks ended June 28, 2025, the Company’s effective income tax rate of 24% differed from the 21% federal corporate income tax rate primarily as a result of state income taxes and the recognition of various discrete tax items. These discrete tax items included a tax benefit of $8 million, primarily related to excess tax benefits associated with share-based compensation.
Net Income
Our net income was $391 million in 2026, compared to a net income of $339 million in 2025. The improvement in net income was due to the relevant factors discussed above.
Liquidity and Capital Resources
Our ongoing operations and strategic objectives require working capital and continuing capital investment. Our primary sources of liquidity include cash provided by operations, as well as access to capital from bank borrowings and other types of debt and financing arrangements. As of June 27, 2026, the Company had approximately $1.8 billion in cash and available liquidity.
Indebtedness
| Debt Description | Maturity | Interest Rate as of June 27, 2026 | Carrying Value as of June 27, 2026 | Carrying Value as of December 27, 2025 |
|---|---|---|---|---|
| ABL Facility | May 28, 2031 | 5.16% | $433 | $429 |
| 2021 Incremental Term Loan Facility (net of $1 and $1 of unamortized deferred financing costs, respectively) | November 22, 2028 | 5.37% | 609 | 609 |
| 2024 Incremental Term Loan Facility (net of $7 and $7 of unamortized deferred financing costs, respectively) | October 3, 2031 | 5.37% | 709 | 712 |
| Senior Notes due 2028 (net of $2 and $3 of unamortized deferred financing costs, respectively) | September 15, 2028 | 6.88% | 498 | 497 |
| Senior Notes due 2029 (net of $3 and $4 of unamortized deferred financing costs, respectively) | February 15, 2029 | 4.75% | 897 | 896 |
| Senior Notes due 2030 (net of $2 and $2 of unamortized deferred financing costs, respectively) | June 1, 2030 | 4.63% | 498 | 498 |
| Senior Notes due 2032 (net of $4 and $4 of unamortized deferred financing costs, respectively) | January 15, 2032 | 7.25% | 496 | 496 |
| Senior Notes due 2033 (net of $2 and $2 of unamortized deferred financing costs, respectively) | April 15, 2033 | 5.75% | 498 | 498 |
| Obligations under financing leases | 2026–2033 | 1.26%-8.31% | 591 | 557 |
| Other debt | January 1, 2031 | 5.75% | 8 | 8 |
| Total debt | 5,237 | 5,200 | ||
| Current portion of long-term debt | (150) | (137) | ||
| Long-term debt | $5,087 | $5,063 |
We had outstanding borrowings totaling $433 million and had issued letters of credit totaling $315 million under the ABL Facility as of June 27, 2026. There was remaining capacity of $1,752 million under the ABL Facility as of June 27, 2026.
As economic conditions permit, we will consider opportunities to repurchase, refinance or otherwise reduce our debt obligations on favorable terms. Any potential debt reduction or refinancing could require significant use of our available liquidity and capital resources.
The agreements governing our indebtedness contain customary covenants. These include, among other things, covenants that may restrict our ability to incur certain additional indebtedness, create or permit liens on our assets, pay dividends, or engage in mergers or consolidations. The Company had approximately $3.1 billion of restricted payment capacity under these covenants and approximately $1.2 billion of its net assets were restricted after taking into consideration the net deferred tax assets and intercompany balances that eliminate in consolidation as of June 27, 2026.
We believe that the combination of cash generated from operations, together with borrowing capacity under the agreements governing our indebtedness and other financing arrangements, will be adequate to permit us to meet our debt service obligations, ongoing costs of operations, working capital needs, and capital expenditure requirements for the next 12 months.
Every quarter, we review rating agency changes for all of the lenders that have a continuing obligation to provide us with funding. We are not aware of any facts that indicate our lenders will not be able to comply with the contractual terms of their agreements with us. We continue to monitor the credit markets generally and the strength of our lender counterparties.
From time to time, we may repurchase or otherwise retire our debt and take other steps to reduce our debt or otherwise improve our leverage. These actions may include open market repurchases, negotiated repurchases, and other retirements of outstanding debt. The amount of debt that may be repurchased or otherwise retired, if any, will depend on market conditions, our debt trading levels, our cash position, and other considerations. Any potential debt reduction or other debt retirement could require significant use of our other available liquidity and capital resources.
See Note 9, Debt, in our consolidated financial statements, for a further description of our indebtedness.
Cash Flows
The following table presents condensed highlights from our Consolidated Statements of Cash Flows for the periods presented:
| 26 weeks ended June 27, 2026 | June 28, 2025 | |
|---|---|---|
| Net income | $391 | $339 |
| Changes in operating assets and liabilities | 7 | 81 |
| Other adjustments | 327 | 305 |
| Net cash provided by operating activities | 725 | 725 |
| Net cash used in investing activities | (175) | (205) |
| Net cash used in financing activities | (535) | (518) |
| Net increase in cash, cash equivalents and restricted cash | 15 | 2 |
| Cash, cash equivalents and restricted cash−beginning of period | 41 | 59 |
| Cash, cash equivalents and restricted cash−end of period | $56 | $61 |
Operating Activities
Cash flows provided by operating activities was $725 million for both the 26 weeks ended June 27, 2026 and June 28, 2025. Higher net income in the current period was offset by favorable changes in operating assets and liabilities in the prior comparative period.
Investing Activities
Cash flows used in investing activities in the 26 weeks ended June 27, 2026 and June 28, 2025 included cash expenditures of $174 million and $161 million, respectively, related to investments in information technology, property and equipment and construction of and improvements to distribution facilities.
During the 26 weeks ended June 28, 2025, the Company completed the asset acquisition of Jake’s Finer Foods. Cash paid for the acquisition of Jake’s Finer Foods was approximately $87 million. Investing activities for the 26 weeks ended June 28, 2025, also included cash proceeds from the sale of Freshway of $38 million.
We expect total cash capital expenditures in fiscal year 2026 to be between $400 million and $440 million. We expect to fund our capital expenditures with available cash or cash generated from operations.
Financing Activities
Cash flows used in financing activities in the 26 weeks ended June 27, 2026 included $4 million in net borrowings under the ABL Facility and $63 million in scheduled payments under our financing leases. The Company incurred approximately $4 million of lender fees and third-party costs in connection with the ABL Facility amendment, which were capitalized as deferred financing costs. Financing activities in the 26 weeks ended June 27, 2026 also included $445 million common stock repurchased under the May 2025 Share Repurchase Program and the November 2025 Share Repurchase Program, $17 million of proceeds received from stock purchases under our employee stock purchase plan, $10 million of proceeds from the exercise of employee stock options, which were offset by $51 million of employee tax withholdings paid in connection with the vesting of stock awards.
Cash flows used by financing activities in the 26 weeks ended June 28, 2025 included $175 million in net payments under the ABL Facility and $77 million in scheduled payments under our financing leases. Financing activities in the 26 weeks ended June 28, 2025 also included $270 million common stock repurchased under the Company’s prior and original share repurchase program initially approved in November 2022, $16 million of proceeds received from stock purchases under our employee stock purchase plan, $5 million of proceeds from the exercise of employee stock options, which were offset by $34 million of employee tax withholdings paid in connection with the vesting of stock awards.
Other Obligations and Commitments
There have been no material changes in the Company’s cash obligations and commitments since the end of fiscal year 2025. Refer to Item 7 of our 2025 Annual Report for additional information regarding the Company’s cash obligations and commitments as of the end of fiscal year 2025.
Retirement Plans
See Note 10, Retirement Plans, in our consolidated financial statements for a description of our retirement plans.
Off-Balance Sheet Arrangements
We had $315 million of letters of credit outstanding primarily securing the Company’s obligations with respect to certain real estate leases, under the ABL Facility as of June 27, 2026.
We held approximately $354 million of surety bonds, as of June 27, 2026 and $362 million as of December 27, 2025, primarily in favor of certain commercial insurers to secure obligations with respect to our insurance programs. In certain cases, surety bonds may be used as an alternative to letters of credit.
Except as disclosed above, we have no off-balance sheet arrangements that currently have or are reasonably likely to have a material effect on our consolidated financial condition, changes in financial condition, results of operations, liquidity, capital expenditures or capital resources.
Critical Accounting Policies and Estimates
We have prepared the financial information in this Quarterly Report in accordance with GAAP. Preparing the Company’s consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during these reporting periods. We base our estimates and judgments on historical experience and other factors we believe are reasonable under the circumstances. These assumptions form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Part II, Item 7—“Management’s Discussion and Analysis of Financial Condition and Results of Operations” of the 2025 Annual Report includes a summary of the critical accounting policies we believe are the most important to aid in understanding our financial results. There have been no changes to those critical accounting policies that have had a material impact on our reported amounts of assets, liabilities, revenue, or expenses during the 26 weeks ended June 27, 2026.
Recent Accounting Pronouncements
For a discussion of recent accounting pronouncements, see Note 2, Recent Accounting Pronouncements, in our consolidated financial statements.
Market risk
As filed, 3,953 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
We are exposed to certain risks arising from both our business operations and overall economic conditions. Our market risks include interest rate risk and fuel price risk. We do not enter into derivatives or other financial instruments for trading or speculative purposes.
Interest Rate Risk
Our debt exposes us to risk of fluctuations in interest rates. Floating rate debt, where the interest rate fluctuates periodically, exposes us to short-term changes in market interest rates. Fixed rate debt, where the interest rate is fixed over the life of the instrument, exposes us to changes in market interest rates reflected in the fair value of the debt and to the risk that we may need to refinance maturing debt with new debt at higher rates. We manage our debt portfolio to achieve an overall desired position of fixed and floating rates and may employ interest rate hedges as a tool to achieve that position. We may, in the future, enter into additional interest rate hedges, the risks of which include changes in the interest rates affecting the fair value of such instruments, potential increases in interest expense due to market increases in floating interest rates and the creditworthiness of the counterparties.
In April 2023, the Company entered into two, two-year interest rate cap agreements, which matured on April 30, 2025 with a total notional amount of $450 million. In April 2025, the Company entered into an interest rate cap agreement with a total notional amount of $450 million that matured on April 30, 2026. In June 2025, the Company entered into an interest rate cap agreement, effective April 30, 2026 with a total notional amount of $450 million that will mature on April 30, 2027.
Through April 30, 2027, the Company has interest rate caps in place that cap the Company’s maximum exposure to the variable component of the interest rate on $450 million of the Term Loan Facilities at 5%, thereby effectively capping the interest rate on approximately 34% of the current outstanding balance of the Term Loan Facilities.
As of June 27, 2026, the Term Loan Facilities, ABL Facility and certain variable rate finance leases, which were approximately 34% of the Company’s total debt, bore interest at a floating rate. A hypothetical 1% change in the applicable rate would cause the interest expense on our floating rate debt to change by approximately $19 million per year (see Note 9, Debt, in our consolidated financial statements).
Fuel Price Risk
We are also exposed to risk due to fluctuations in the price and availability of diesel fuel. We require significant quantities of diesel fuel for our vehicle fleet, and the price and supply of diesel fuel are unpredictable and fluctuate based on events outside our control, including geopolitical developments, supply and demand for oil and gas, regional production patterns, weather conditions and environmental concerns. Increases in the cost of diesel fuel can negatively affect consumer confidence and discretionary spending and increase the prices we pay for products, and the costs we incur to deliver products to our customers.
Fuel costs related to outbound deliveries approximated $174 million during the fiscal year ended December 27, 2025. Our activities to minimize fuel cost risk include route optimization, improving fleet utilization, growing our fleet of electric vehicles and assessing fuel surcharges. We also enter into forward purchase commitments for a portion of our projected diesel fuel requirements. As of June 27, 2026, our diesel fuel forward purchase commitments lock approximately 33% of our projected gallons of diesel fuel needs through December 2026. Using current published market price projections for diesel and estimated fuel consumption needs, a hypothetical 10% unfavorable change in diesel prices from the market price could result in approximately $7 million in additional fuel cost on uncommitted volumes through December 2026.
Controls and procedures
As filed, 1,842 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is processed, recorded, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that this information is accumulated and communicated to Company management, including our Chair of the Board and Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.
As required by Exchange Act Rule 13a-15(b), we carried out an evaluation, under the supervision and with the participation of management, including our Chair of the Board and Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report. Based on this evaluation, our Chair of the Board and Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of June 27, 2026.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting during the fiscal quarter ended June 27, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 233 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes to the principal risks that we believe are material to our business, results of operations, and financial condition from those disclosed in Part I, Item 1A—“Risk Factors” of the 2025 Annual Report.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2026-06-27. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2026-03-29 to 2026-06-27 | $10.53bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2025-12-28 to 2026-06-27 | $20.14bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2026-03-29 to 2026-06-27 | $8.61bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2025-12-28 to 2026-06-27 | $16.57bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2026-03-29 to 2026-06-27 | $1.92bn | us-gaap:GrossProfit |
| Gross profit | 6 months2025-12-28 to 2026-06-27 | $3.57bn | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2026-03-29 to 2026-06-27 | $1.48bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2025-12-28 to 2026-06-27 | $2.91bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2026-03-29 to 2026-06-27 | $443.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2025-12-28 to 2026-06-27 | $659.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2026-03-29 to 2026-06-27 | $77.0m | us-gaap:InterestExpenseNonoperating |
| Interest expense | 6 months2025-12-28 to 2026-06-27 | $152.0m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months2026-03-29 to 2026-06-27 | $94.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2025-12-28 to 2026-06-27 | $120.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2026-03-29 to 2026-06-27 | $275.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2025-12-28 to 2026-06-27 | $391.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2026-03-29 to 2026-06-27 | $1.24 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2025-12-28 to 2026-06-27 | $1.76 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2026-03-29 to 2026-06-27 | $1.26 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2025-12-28 to 2026-06-27 | $1.78 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2026-03-29 to 2026-06-27 | 221,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2025-12-28 to 2026-06-27 | 222,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2025-12-28 to 2026-06-27 | $725.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2025-12-28 to 2026-06-27 | $174.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months2025-12-28 to 2026-06-27 | $445.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2026-06-27 | $56.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2026-06-27 | $4.45bn | us-gaap:AssetsCurrent |
| Total assets | At period end2026-06-27 | $14.34bn | us-gaap:Assets |
| Current liabilities | At period end2026-06-27 | $3.91bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2026-06-27 | $10.06bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2026-06-27 | $4.28bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001665918-26-000045. Last ingested by Listed: Nov 14, 2026, 12:55 ET. Listed shows no prices and gives no investment advice.